mestranol has been researched along with Endometrial Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Burchardt, NA; Fortner, RT; Kaaks, R; Shafrir, AL; Tworoger, SS | 1 |
| Coppens, M; Thiery, M | 1 |
| Mizunuma, H | 1 |
1 review(s) available for mestranol and Endometrial Neoplasms
| Article | Year |
|---|---|
[Treatment of osteoporosis with estrogen].
Topics: Bone Density; Breast Neoplasms; Endometrial Neoplasms; Estriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mestranol; Osteoporosis, Postmenopausal; Risk | 2004 |
2 other study(ies) available for mestranol and Endometrial Neoplasms
| Article | Year |
|---|---|
Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.
Topics: Adult; Aged; Cohort Studies; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Estrogens; Ethinyl Estradiol; Female; Humans; Mestranol; Middle Aged; Progestins; Prospective Studies | 2021 |
Endometrial response to the use of a sequential oral contraceptive.
Topics: Anatomy; Belgium; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Endocrine System; Endometrial Neoplasms; Endometrium; Europe; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Mestranol; Neoplasms; Norethindrone; Physiology; Reproductive Control Agents; Risk Factors; Urogenital System; Uterus | 1988 |